Alkylamine derivative
USRE49569E1 · kind E1 · reissue
0Cited by
17References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 1, 2021 |
| Grant date | Jul 4, 2023 |
| Priority date | — |
| Expiry date | Apr 1, 2041 |
Classification
- Technology area (CPC —)General
Abstract
A composition containing a compound represented by General Formula (I) below (see the definition in the specification for the symbols in the formula) or a salt thereof has an excellent CaSR agonistic effect and provides a pharmaceutical agent, a CaSR agonistic agent, a prophylactic or therapeutic agent for a disease that can be ameliorated through CaSR activation as well as seasonings and an agent for imparting kokumi.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.